homeostasis/metabolism
N |
• no changes in plasma lipid levels (total cholesterol, phospholipids, triglycerides)
• plasma ceramide levels similar to controls
|
• plasma sphingomyelin reduced to 52% of control level
• liver sphingomyelin levels reduced to 36% of control levels
• 65% less sphingomyelin in macrophage cell membranes
|
• liver ceremide levels decreased to 26% of controls
• liver glucosylceramide levels increased 12X
• liver GM3 levels increased 7X
• 8.5 fold more glucosylceramide and 6.2 fold more GM3 in macrophage cell membranes
• plasma glucosylceramide levels increased 7 fold
• plasma GM3 levels increased 6 fold
|
• significantly decreased plasma levels of IL-6 after LPS stimulation
|
• significantly decreased plasma levels of TNF alpha after LPS stimulation
|
immune system
• significantly decreased plasma levels of IL-6 after LPS stimulation
|
• significantly decreased plasma levels of TNF alpha after LPS stimulation
|
• attenuated LPS mediated IL-6 secretion from macrophage
|
• attenuated LPS mediated TNF alpha secretion from macrophage
|